))
Let's Talk MS Medical cannabis and low-dose naltrexone
Manage episode 380277860 series 3454133
Sisällön tarjoaa MS-UK. MS-UK tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
How helpful is cannabis-based medication for people with multiple sclerosis? Ian Cook speaks to Professor Mike Barns, Chief Medical Officer at Drug Science, a group which works to provide an evidence base free from political or commercial influence. Proff Barns explains the work they are doing to make accessing cannabis-based medicine easier to access for people with multiple sclerosis, and how it can benefit patients.
We also hear from an MS patient who has been prescribed Sativex, a licenced cannabis-based medication, and their experiences with it.
Low-dose naltrexone is an off-licence medication that some people with MS say improves their symptoms. Linda Elsegood is the founder of The LDN Trust and has made it her life's work to try to get people with MS access to this drug. She tells Ian how the treatment completely changed her life.
5 jakso
Jaa
